RB1 gene mutations in Argentine retinoblastoma patients. Implications for genetic counseling
Open Access
- 20 December 2017
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 12 (12) , e0189736
Abstract
Retinoblastoma (RB) is an inherited childhood ocular cancer caused by mutations in the tumor suppressor RB1 gene. Identification of RB1 mutations is essential to assess the risk of developing retinoblastoma in the patients´ relatives. Retinoblastoma is a potentially curable cancer and an early diagnosis is critical for survival and eye preservation. Unilateral retinoblastoma is mostly non-heritable and results from two somatic mutations whereas bilateral retinoblastoma is heritable and results from one germline and one somatic mutation, both have high penetrance, 90%. The purpose of this study was to identify causative RB1 mutations in RB patients with different clinical presentations. A comprehensive approach was used to study a cohort of 34 patients with unilateral, bilateral and trilateral retinoblastoma. Blood and tumor DNA was analyzed by sequencing and multiplex ligation-dependent probe amplification (MLPA) assay. Validation of an insertion mutation was performed by cloning the PCR product. Most of the patients in our cohort had unilateral RB, eight patients had bilateral RB and one patient had a trilateral tumor with ocular and suprasellar/sellar locations. Other tumors in addition to retinoblastoma were also found in the affected families. One patient had two syndromes, retinoblastoma and schwannomatosis, and another RB patient had a father with a retinoma. Five out of the 25 unilateral RB patients carried germinal mutations (20%), which were mostly missense mutations. The bilateral and trilateral patients carried splice-site, nonsense and frameshift mutations as well as a whole RB1 gene deletion. Missense mutations were associated with mild phenotype: unilateral retinoblastoma, retinoma or no tumor. In this study we identified causative RB1 mutations in most bilateral RB patients and in some unilateral RB patients, including five novel mutations. These data are crucial for genetic counseling and confirm the need to perform complete genetic screening for RB1 mutations in both constitutional and tumor tissues.Keywords
Funding Information
- Universidad de Buenos Aires (20020090200492)
This publication has 31 references indexed in Scilit:
- Deciphering the retinoblastoma protein phosphorylation codeTrends in Biochemical Sciences, 2013
- Structures of inactive retinoblastoma protein reveal multiple mechanisms for cell cycle controlGenes & Development, 2012
- Frequency of SMARCB1 mutations in familial and sporadic schwannomatosisneurogenetics, 2012
- Low penetrance of retinoblastoma for p.V654L mutation of the RB1 geneBMC Medical Genetics, 2011
- Crystal structure of the unliganded retinoblastoma protein pocket domainProteins: Structure, Function, and Bioinformatics, 2011
- Strategies to manage retinoblastoma in developing countriesPediatric Blood & Cancer, 2010
- A 5′ Splice Site Enhances the Recruitment of Basal Transcription Initiation Factors In VivoMolecular Cell, 2008
- Genotype–phenotype correlations in hereditary familial retinoblastomaHuman Mutation, 2007
- Retinoblastoma: the disease, gene and protein provide critical leads to understand cancerSeminars in Cancer Biology, 2000
- Mutation and Cancer: Statistical Study of RetinoblastomaProceedings of the National Academy of Sciences, 1971